CompletedNCT04605393
Official study titleDoes Cannabidiol Attenuate the Acute Effects of ∆9-tetrahydrocannabinol Intoxication in Individuals Diagnosed With Schizophrenia? A Double-blind, Randomised, Placebo-controlled Experimental Study
This study has finished and is no longer accepting participants.
In LondonSchizophreniaMedication studyAges 18–65
- Countries
- United Kingdom
- Sponsor
- King's College London (University)
CompletedNCT07541157
Official study titleThe Effect of Ashwagandha Therapy as an Adjunct on Serum BDNF Levels and Cognitive Function in Schizophrenia Patients Receiving Risperidone: A Double-Blind Randomized Controlled Trial
This study has finished and is no longer accepting participants.
In MakassarSchizophreniaMedication studyAges 20–45
- Countries
- Indonesia
- Sponsor
- Hasanuddin University
CompletedNCT07524868
Official study titleEffectiveness of Cognitive Behavioral Therapy as an Adjunctive Treatment on Auditory Hallucinations and Neutrophil-to-Lymphocyte Ratio in Patients With Schizophrenia Receiving Risperidone
This study has finished and is no longer accepting participants.
In MakassarSchizophreniaMedication studyAges 20–50
- Countries
- Indonesia
- Sponsor
- Hasanuddin University
CompletedNCT07523256
Official study titleThe Effect of Adjuvant Curcumin Extract on Quality of Life and Interleukin-1 Beta (IL-1β) Levels in Patients With Schizophrenia Receiving Risperidone: A Randomized Clinical Trial
This study has finished and is no longer accepting participants.
In MakassarSchizophreniaMedication studyAges 20–45
- Countries
- Indonesia
- Sponsor
- Rinvil Renaldi
UnknownNCT06573320
Official study titleInvestigating the Effect of Exercise on Clinical Symptoms, Cognitive Performance, and Quality of Life in Schizophrenia Patients Treated With Clozapine
Current recruitment status is unconfirmed.
In IstanbulSchizophreniaInterventional studyAges 18–65
- Countries
- Türkiye
- Sponsor
- Dr. Lutfi Kirdar Kartal Training and Research Hospital
CompletedNCT07365982
Official study titleTHE EFFECT OF PSYCHOEDUCATION-BASED MOTIVATIONAL INTERVIEWING ON KNOWLEDGE ABOUT SCHIZOPHRENIA AND HOPE LEVELS IN PATIENTS DIAGNOSED WITH SCHIZOPHRENIA
This study has finished and is no longer accepting participants.
In IstanbulSchizophreniaBehavioural studyAges 18–65
- Countries
- Türkiye
- Sponsor
- Büşra Taşkıner
CompletedNCT03497013
Official study titleEffect of tDCS on Cognition, Symptoms in Chronic Schizophrenia Patients With Tardive dyskinesia_a Randomized, Double-blind, Sham-controlled Trial
This study has finished and is no longer accepting participants.
In SuzhouSchizophreniaDevice studyAges 18–70
- Countries
- China
- Sponsor
- Suzhou Psychiatric Hospital
UnknownNCT06588270
Official study titleEffect of Virtual Reality-based Therapy on Negative Symptoms in People with Schizophrenia: Study Protocol for a Randomized Controlled Trial
Current recruitment status is unconfirmed.
In SantiagoSchizophreniaBehavioural studyAges 18–65
- Countries
- Chile
- Sponsor
- Hospital de la Florida Dra. Eloiza Diaz
CompletedNCT03930225
This study has finished and is no longer accepting participants.
In Al MansurahSchizophreniaBehavioural studyAges 18–50
- Countries
- Egypt
- Sponsor
- Mansoura University
CompletedNCT05229484
Official study titleEffects of an Integrated Multimodal Lifestyle Intervention for Management of Violence Through Regulation of Serum Lipid Profile in Schizophrenia: A Randomized Controlled Trial
This study has finished and is no longer accepting participants.
In Kaohsiung CitySchizophreniaInterventional studyAges 20–65
- Countries
- Taiwan
- Sponsor
- I-Shou University
Active Not RecruitingNCT04783571
This study is no longer accepting new participants.
In BostonSchizophreniaPlacebo researchAges 18–50
- Countries
- United States
- Sponsor
- Massachusetts General Hospital (Hospital / academic medical center)
CompletedNCT05207319
Official study titleEffects of Integrated Moral Reasoning Development Intervention for Management of Violence in Schizophrenia: A Randomized Controlled Trial
This study has finished and is no longer accepting participants.
In Kaohsiung CitySchizophreniaInterventional studyAges 20–65
- Countries
- Taiwan
- Sponsor
- I-Shou University
